IOVA Stock Jumps 35% On Positive Data
IOVA stock is on fire in Thursday’s session after Iovance Biotherapeutics Inc (NASDAQ:IOVA) announced positive results for its LN 145, an advanced cervical cancer drug. California-based biotechnology company, Iovance Biotherapeutics, has been one of the ... [Read]
Iovance Biotherapeutics Webcasting its Analyst Day on December 13
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) will be webcasting its Analyst Day on Wednesday, December 13 from 9:00 am to 12:00 pm EST. The event, being held in New York City, will highlight Iovance’s lead clinical programs. ... [Read]
A Closer Look at Iovance Biotherapeutics Inc.’s Recent Trading Lows
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) recently had a low trading volume day. The volume for the company on November 13th was recorded to 0.39 million contracts. Over the past three months, the average daily trading volume ... [Read]
Iovance Biotherapeutic Inc Sees Comeback From 12-Month Low
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) saw a 56.18% comeback from a 12-month low price of $4.45. It was seen 4.51% higher, changing the price to $6.95, when the closing bell rang on October 25th. During the ... [Read]
Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering
Iovance Biotherapeutics, Inc (NASDAQ:$IOVA) has announced pricing for their $50 million common stock offering. The company will offer 7,692,308 shares of its common stock at the price of $6.50 per share. Gross profits from this ... [Read]
This is Why Right Now is the Best Time to Buy Iovance Biotherapeutics
Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) is a huge mover this week as shares have increased 5.10%, or $0.4 during the last trading session. In total, about 568,977 shares have been traded, 39.85% up from the average. ... [Read]